Carcinogenesis Advance Access originally published online on June 5, 2003
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Carcinogenesis, Vol. 24, No. 8, 1389-1399,
August 2003
© 2003 Oxford University Press
CARCINOGENESIS |
Phenobarbital at low dose exerts hormesis in rat hepatocarcinogenesis by reducing oxidative DNA damage, altering cell proliferation, apoptosis and gene expression
1 Department of Pathology, Osaka City University Medical School, Abeno-ku, Asahi-machi 1-4-3, Osaka 545-8585, Japan
2 Department of Chemical Biology, Osaka City University Medical School, Abeno-ku, Asahi-machi 1-4-3, Osaka 545-8585, Japan
4 To whom correspondence should be addressed Email: fukuchan{at}med.osaka-cu.ac.jp
Our recent research indicated that phenobarbital (PB) may inhibit the development of N-diethylnitrosamine (DEN)-initiated pre-neoplastic lesions at low doses in a rat liver medium-term bioassay (Ito test), while high doses exhibit promoting activity. This raises the question of whether treatment with low doses of PB might reduce cancer risk. For clarification, male 6-week-old F344 rats were treated with PB at doses of 0, 2, 15 and 500 p.p.m. in the diet for 10 or 33 weeks after initiation of hepatocarcinogenesis with DEN. In a second, short-term experiment, animals were given PB at doses of 2, 4, 15, 60 and 500 p.p.m. for 8 days. Formation of glutathione S-transferase placental form (GST-P) positive foci and liver tumors was inhibited at 2 p.p.m. Generation of oxidative DNA damage marker, 8-hydroxy-2'-deoxyguanosine (8-OHdG), cellular proliferation within the areas of GST-P positive foci and apoptosis in background liver parenchyma were suppressed. Suppression of 8-OHdG formation by PB at low dose might be related to the enhanced mRNA expression of 8-OHdG repair enzyme, oxoguanine glycosylase 1 (Ogg1). Moreover, as detected by cDNA microarray analysis, PB treatment at low dose enhanced mRNA expression of glutamic acid decarboxylase (GAD65), an enzyme involved in the synthesis of gamma-aminobutyric acid (GABA), and suppressed MAP kinase p38 and other intracellular kinases gene expression. On the contrary, when PB was applied at a high dose, GST-P positive foci numbers and areas, tumor multiplicity, hydroxyl radicals and 8-OHdG levels were greatly elevated with the increase in CYP2B1/2 and CYP3A2 mRNA, protein, activity and gene expression of GST, nuclear tyrosine phosphatase, NADPH- cytochrome P-450 reductase and guanine nucleotide binding protein G(O) alpha subunit. These results indicate that PB exhibits hormetic effect on rat hepatocarcinogenesis initiated with DEN by differentially altering cell proliferation, apoptosis and oxidative DNA damage at high and low doses.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  N. Bhattacharjee, S. Pathak, and A. R. Khuda-Bukhsh Amelioration of Carcinogen-Induced Toxicity in Mice by Administration of a Potentized Homeopathic Drug, Natrum Sulphuricum 200 Evid. Based Complement. Altern. Med., March 1, 2009; 6(1): 65 - 75. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Takahashi, M. Shibutani, G.-H. Woo, K. Inoue, H. Fujimoto, K. Igarashi, J. Kanno, M. Hirose, and A. Nishikawa Cellular distributions of molecules with altered expression specific to the tumor promotion process from the early stage in a rat two-stage hepatocarcinogenesis model Carcinogenesis, November 1, 2008; 29(11): 2218 - 2226. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Aluru and M. M. Vijayan Hepatic transcriptome response to glucocorticoid receptor activation in rainbow trout Physiol Genomics, November 14, 2007; 31(3): 483 - 491. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Moto, M. Okamura, M. Muguruma, T. Ito, M. Jin, Y. Kashida, and K. Mitsumori Gene Expression Analysis on the Dicyclanil-Induced Hepatocellular Tumors in Mice Toxicol Pathol, October 1, 2006; 34(6): 744 - 751. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Nishikawa-Ogawa, H. Wanibuchi, K. Morimura, A. Kinoshita, T. Nishikawa, S. Hayashi, Y. Yano, and S. Fukushima N-acetylcysteine and S-methylcysteine inhibit MeIQx rat hepatocarcinogenesis in the post-initiation stage Carcinogenesis, May 1, 2006; 27(5): 982 - 988. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Asano, D. K. Torous, C. R. Tometsko, S. D. Dertinger, T. Morita, and M. Hayashi Practical threshold for micronucleated reticulocyte induction observed for low doses of mitomycin C, Ara-C and colchicine Mutagenesis, January 1, 2006; 21(1): 15 - 20. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Fukushima, A. Kinoshita, R. Puatanachokchai, M. Kushida, H. Wanibuchi, and K. Morimura Hormesis and dose-response-mediated mechanisms in carcinogenesis: evidence for a threshold in carcinogenicity of non-genotoxic carcinogens Carcinogenesis, November 1, 2005; 26(11): 1835 - 1845. [Abstract] [Full Text] [PDF]
|
|